Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-17-025877

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BURGESS DANIEL D Director 2017-06-21 Grant or award · Director Stock Option Grant (Right to Buy) +22,000 22,000 D: show line 1 in the form
Loading xslF345X03/doc1.xml…